Disclosure Panels Details Page
Ovarian Cancer Panel - Disclosures as of 11/22/2016
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Has Attended |
|---|---|---|---|---|---|
| Deborah Armstrong MD | AstraZeneca Pharmaceuticals LP clovis |
Eviti/Nant Health Morphotek Inc. |
None | None | ✔ |
| Jamie Bakkum-Gamez MD | None | None | None | None | ✔ |
| Lisa Barroilhet MD, MSc | None | None | None | None | ✔ |
| Kian Behbakht MD | None | None | None | None | ✔ |
| Marian Birkeland PhD | None | None | None | None | - |
| Jennifer Burns BS | None | None | None | None | ✔ |
| Lee-May Chen MD | None | None | None | None | - |
| Alycia Corrigan | None | None | None | None | - |
| Marta Ann Crispens MD | AstraZeneca Pharmaceuticals LP Janssen Pharmaceutica Products, LP |
None | None | None | ✔ |
| Marie DeRosa RN | None | None | None | None | ✔ |
| Oliver Dorigo MD, PhD | None | Clovis Oncology ASCO Rucaparib Advisory Board Meeting on Sunday, June 5, 2016 | Foundation Medicine, Inc. | None | - |
| David Gershenson MD | National Cancer Institute | None | None | AbbVie, Inc.|Biogen Idec|Celgene Corporation|Elsevier|GSK|Johnson & Johnson|Merck & Co., Inc.|Pfizer Inc.|Proctor and Gamble|UpToDate | ✔ |
| Heidi Gray MD | None | None | None | None | ✔ |
| Kristina Gregory MSN, RN | None | None | None | None | - |
| Ardeshir Hakam MD | None | None | None | None | ✔ |
| Evelyn Handel PharmD, BCOP, BCPS | None | None | None | None | ✔ |
| Laura Havrilesky MD | AstraZeneca Pharmaceuticals LP | None | None | None | ✔ |
| Miranda Hughes PhD | None | None | None | None | ✔ |
| Carolyn Johnston MD | None | None | external advisor/mentor for gyn oncology fellowship in Ethiopia and in Ghana Michigan Cancer Consortium MPRO |
american cancer society document reviewer|michigan cancer consortium|MIOCA|see 5c | - |
| Shashikant Lele MD | None | None | None | None | - |
| Lainie Martin MD | Novartis Pharmaceuticals Corporation Synta Pharmaceuticals Corp. |
Immunogen | None | None | ✔ |
| Ursula Matulonis MD | None | AstraZeneca Pharmaceuticals LP Clovis Eli Lilly and Company Genentech, Inc. Immunogen Merck & Co., Inc. |
None | None | ✔ |
| Joan McClure MS | None | None | None | None | ✔ |
| Robert Morgan MD, FACP | None | None | None | None | - |
| David O'Malley MD | None | Amgen Inc. Clovis Genentech, Inc. Janssen Pharmaceutica Products, LP novocure Tesaro |
None | None | ✔ |
| Richard Penson MD, MRCP | Amgen Inc. AstraZeneca Pharmaceuticals LP Endocyte Inc. Genentech, Inc. Vascular Biogenics Ltd |
AstraZeneca Pharmaceuticals LP Genentech, Inc. Vascular Biogenics, Ltd |
None | None | ✔ |
| Sanja Percac-Lima MD, PhD | None | None | None | None | ✔ |
| Mario Pineda MD, PhD | None | None | None | None | - |
| Steven Plaxe MD, FACOG, FACS | Amgen Inc. AstraZeneca Pharmaceuticals LP azaya bind endocyte Janssen Pharmaceutica Products, LP Millennium Pharmaceuticals, Inc. navidia Novartis Pharmaceuticals Corporation Pfizer Inc. pharma mar Tesaro |
None | None | Abbott Laboratories|Bristol Myers Squibb | ✔ |
| Donna Powell DHSc, CMD, RT(T) | None | None | None | None | - |
| Matthew Powell MD | None | AstraZeneca Pharmaceuticals LP Genentech, Inc. |
AstraZeneca Pharmaceuticals LP Genentech, Inc. |
None | ✔ |
| Elena Ratner MD, MBA | None | None | None | None | ✔ |
| Steven Remmenga MD | None | None | None | None | - |
| Peter Rose MD | None | None | None | None | ✔ |
| Paul Sabbatini MD | Bristol Myers Squibb | None | None | None | ✔ |
| Joseph Santoso MD | None | None | None | None | ✔ |
| Jack Skinner PhD | None | None | None | None | ✔ |
| Theresa Werner MD | None | None | None | None | ✔ |